Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irinotecan”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004139
What this trial is testing

Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 80
Testing effectiveness (Phase 2)Study completedNCT00433381
What this trial is testing

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult GlioblastomaAdult GliosarcomaRecurrent Adult Brain Neoplasm
National Cancer Institute (NCI) 123
Testing effectiveness (Phase 2)Ended earlyNCT00636805
What this trial is testing

Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With Bevacizumab

Who this might be right for
Brain Cancer
Duke University 63
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Testing effectiveness (Phase 2)Ended earlyNCT01926769
What this trial is testing

A Phase II Study to Determine the Safety and Efficacy of Second-line Treatment With Metformin and Chemotherapy (FOLFOX6 or FOFIRI) in the Second Line Threatment of Advanced Colorectal Cancer

Who this might be right for
Previously Treated Advanced Colorectal Cancer
Gachon University Gil Medical Center 2
Testing effectiveness (Phase 2)Study completedNCT00989469
What this trial is testing

Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation

Who this might be right for
Metastatic Colorectal Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 64
Testing effectiveness (Phase 2)Looking for participantsNCT07831369
What this trial is testing

VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma

Who this might be right for
GlioblastomaAstrocytoma, IDH-Mutant, Grade 4
Inova Health Care Services 52
Early research (Phase 1)Study completedNCT02906059
What this trial is testing

Study of Irinotecan and AZD1775, a Selective Wee 1 Inhibitor, in RAS or BRAF Mutated, Second-line Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
NYU Langone Health 7
Early research (Phase 1)Study completedNCT01528046
What this trial is testing

Metformin in Children With Relapsed or Refractory Solid Tumors

Who this might be right for
Solid TumorsPrimary Brain Tumors
H. Lee Moffitt Cancer Center and Research Institute 26
Large-scale testing (Phase 3)Study completedNCT01640405
What this trial is testing

Study of 5-Fluorouracil/Leucovorin/Oxaliplatin (FOLFOX) + Bevacizumab Versus 5-Fluorouracil/Leucovorin/Oxaliplatin/Irinotecan (FOLFOXIRI) + Bevacizumab as First Line Treatment of Patients With Metastatic Colorectal Cancer Not Previously Treated and With Three or More Circulating Tumoral Cells

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 350
Early research (Phase 1)Looking for participantsNCT06006273
What this trial is testing

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Who this might be right for
Refractory Solid Tumors
M.D. Anderson Cancer Center 48
Early research (Phase 1)Looking for participantsNCT06995872
What this trial is testing

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01923337
What this trial is testing

Irinotecan and Alisertib in Treating Patients With Advanced Solid Tumors or Colorectal Cancer

Who this might be right for
Mucinous Adenocarcinoma of the ColonMucinous Adenocarcinoma of the RectumRecurrent Colon Cancer+5 more
University of California, Davis 17
Testing effectiveness (Phase 2)UnknownNCT03484195
What this trial is testing

Neoadjuvant FOLFOXIRI Chemotherapy in Patients With Locally Advanced Colon Cancer

Who this might be right for
Colonic NeoplasmsDrug Therapy
China Medical University, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT07542002
What this trial is testing

Liposomal Irinotecan, 5-fluorouracil/Calcium Folinate, Oxaliplatin, and Adebrelimab in Combination With Radiotherapy for Resectable or Borderline Resectable Pancreatic Cancer With Risk Factors：A Prospective Exploratory Study

Who this might be right for
Pancreatic Cancer
Ningbo Medical Center Lihuili Hospital 37
Testing effectiveness (Phase 2)Study completedNCT02323737
What this trial is testing

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Chinese Academy of Medical Sciences 62
Post-approval studies (Phase 4)Temporarily pausedNCT02366819
What this trial is testing

Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

Who this might be right for
Esophageal AdenocarcinomaGastric AdenocarcinomaStage IIB Gastric Cancer+6 more
University of Chicago 36
Testing effectiveness (Phase 2)Ended earlyNCT00183807
What this trial is testing

Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Southern California 6
Testing effectiveness (Phase 2)Looking for participantsNCT07346157
What this trial is testing

Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease

Who this might be right for
MedulloblastomaMedulloblastoma, ChildhoodMedulloblastoma Recurrent
Sabine Mueller, MD, PhD 69
Large-scale testing (Phase 3)UnknownNCT03651219
What this trial is testing

Mesylate Apatinib Combined With Irinotecan in Treatment of Recurrent Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Beijing Chest Hospital 90
Next Page